SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

STRYKER CORP

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026

$297.94+3.28 (+1.11%)

Close on Oct 19, 2026

Market cap: $115.00B
P/E (TTM): 30.9
Dividend yield: –

Fundamental chart

Pick a measure to chart its full history

$25.12BFY2025, +8.2% a year since FY2011

Where these numbers come from

Parsed from the XBRL in Stryker's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on May 17, 2004
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SYK.

Revenue growth8.5% · median 13.5%

Gross margin65.0% · median 46.9%

Operating margin21.4% · median 10.7%

Net margin14.4% · median -2.6%

Company	Revenue	Growth
SYK	$25.84B	+8.5%
BDX	$23.25B	+17.4%
BSX	$21.00B	+13.5%
BAX	$11.47B	+5.4%
SNN	–	–
MDLN	–	–

Company

Next earnings (est.): Oct 29, 2026, after close
Exchange: NYSE
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 56,000
Held by institutions: 80.2%
Auditor: Ernst& Young LLP
SEC CIK: 310764

Advertisement
300 × 250